A. Azzouqa

发表

Reducing Unplanned Medical Oncology Readmissions by Improving Outpatient Care Transitions: A Process Improvement Project at the Cleveland Clinic.

A. Khorana, M. Kalaycio, R. Lagman, 2016, Journal of oncology practice.

Reduction of Inappropriate Prophylactic Pegylated Granulocyte Colony-Stimulating Factor Use for Patients With Non-Small-Cell Lung Cancer Who Receive Chemotherapy: An ASCO Quality Training Program Project of the Cleveland Clinic Taussig Cancer Institute.

V. Velcheti, N. Pennell, J. Stevenson, 2016, Journal of oncology practice.

Emerging therapeutic agents for advanced non-small cell lung cancer

Y. Lou, R. Manochakian, Yujie Zhao, 2020, Journal of Hematology & Oncology.

Impact of good and poor mobilizers on hematopoietic progenitor cell collection efficiency and product quality

V. Roy, A. Zubair, A. Azzouqa, 2018, Journal of clinical apheresis.

The evolution of the diminishing role of extrapleural pneumonectomy in the surgical management of malignant pleural mesothelioma

J. Stevenson, A. Azzouqa, 2016, OncoTargets and therapy.

Monoclonal antibody utilization characteristics in patients with multiple myeloma.

R. Fonseca, A. Chanan-Khan, V. Roy, 2019, Anti-cancer drugs.

Association of CDKN2A gene alteration with high expression of PD-L1.

Y. Lou, R. Manochakian, J. Marin-Acevedo, 2018 .

Myelodysplasia-related acute myeloid leukemia and acute promyelocytic leukemia: concomitant occurrence of two molecularly distinct diseases

J. Foran, P. Vishnu, D. Menke, 2018, Hematology reports.

Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities

D. Hodge, A. Chanan-Khan, V. Roy, 2019, Clinical Lymphoma Myeloma and Leukemia.

The evolution of the diminishing role of extrapleural pneumonectomy in the surgical management of malignant pleural mesothelioma

J. Stevenson, A. Azzouqa, 2016, OncoTargets and therapy.